Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CHOP”

415 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 415 results

Not applicableStudy completedNCT02461290
What this trial is testing

Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1

Who this might be right for
Follicular Lymphoma
Hoffmann-La Roche 99
Testing effectiveness (Phase 2)UnknownNCT00005959
What this trial is testing

Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Amgen
Large-scale testing (Phase 3)Study completedNCT01796002
What this trial is testing

Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
The Lymphoma Academic Research Organisation 421
Not applicableWithdrawnNCT04293900
What this trial is testing

Diet, Physical Activity and Body Composition Changes During R-CHOP

Who this might be right for
Non-Hodgkin LymphomaDLBCLDiffuse Large B Cell Lymphoma
George Washington University
Not applicableStudy completedNCT03211702
What this trial is testing

Geriatric Assessments in Elderly Diffuse Large B-cell Lymphoma Patients-2 (GERIAD2)

Who this might be right for
Lymphoma, Large B-cell, Diffuse
Chonbuk National University Hospital 100
Large-scale testing (Phase 3)Ended earlyNCT01287741
What this trial is testing

Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche 1,418
Large-scale testing (Phase 3)Ended earlyNCT00486759
What this trial is testing

Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
Hoffmann-La Roche 787
Testing effectiveness (Phase 2)UnknownNCT02792491
What this trial is testing

Phase II Prospective Trial of Addition of Rituximab to Reduced Dose CHOP Chemotherapy in DLBC L Patients Aged 65 Years and Over

Who this might be right for
Diffuse Large B-cell Lymphoma
Pusan National University Hospital 57
Testing effectiveness (Phase 2)Study completedNCT00117897
What this trial is testing

Treatment for Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Amgen
Testing effectiveness (Phase 2)Study completedNCT00309881
What this trial is testing

Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 75
Testing effectiveness (Phase 2)Study completedNCT00290667
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 586
Not applicableStudy completedNCT04726995
What this trial is testing

DLBCL Treatment in Children and Adolescents

Who this might be right for
Diffuse Large B-cell Lymphoma
Sun Yat-sen University 106
Testing effectiveness (Phase 2)Study completedNCT01157988
What this trial is testing

90Y-ibritumomab Tiuxetan Consolidation After 6th R-CHOP Chemotherapy in Patients With Bulky Diffuse Large B Cell Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Chonnam National University Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04835870
What this trial is testing

Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL

Who this might be right for
Non-GCB/ABC Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital of Soochow University 78
Large-scale testing (Phase 3)Study completedNCT05051891
What this trial is testing

A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma

Who this might be right for
Treatment-naїve Mantle Cell Lymphoma
Beijing InnoCare Pharma Tech Co., Ltd. 3
Testing effectiveness (Phase 2)UnknownNCT05238064
What this trial is testing

Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCL

Who this might be right for
PI3Kδ InhibitorParsaclisibCHOP+1 more
Fudan University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06594432
What this trial is testing

Molecular Subtype-Guided R-CHOP-MTX±Zanubrutinib Treatment in Newly Diagnosed DLBCL Patients with Central Nervous System Involvement

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)UnknownNCT04423926
What this trial is testing

Lenalidomide in Combination With CHOP in Patients With Untreated PTCL

Who this might be right for
PTCL, NOSAITLALK- ALCL+2 more
The First Affiliated Hospital with Nanjing Medical University 91
Testing effectiveness (Phase 2)Study completedNCT02073097
What this trial is testing

Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma

Who this might be right for
Contiguous Stage II Adult Diffuse Large Cell LymphomaNoncontiguous Stage II Adult Diffuse Large Cell LymphomaStage I Adult Diffuse Large Cell Lymphoma+2 more
Case Comprehensive Cancer Center 48
Testing effectiveness (Phase 2)UnknownNCT05887726
What this trial is testing

Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors

Who this might be right for
Diffuse Large B Cell Lymphoma
Liaoning Cancer Hospital & Institute 30
Load More Results